| Authors: |
Pascual J; Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Lim JSJ; National University Cancer Institute, Singapore (NCIS), National University Hospital, Singapore., Macpherson IR; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Armstrong AC; Department of Medical Oncology, Christie Hospital NHS Foundation Trust and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Ring A; Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Okines AFC; Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Cutts RJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Herrera-Abreu MT; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Garcia-Murillas I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Pearson A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Hrebien S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Gevensleben H; University Hospital Bonn, Bonn, Germany., Proszek PZ; Centre for Molecular Pathology, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Hubank M; Centre for Molecular Pathology, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Hills M; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., King J; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Parmar M; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Prout T; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Finneran L; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Malia J; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Swales KE; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Ruddle R; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Raynaud FI; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Turner A; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Hall E; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Yap TA; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Lopez JS; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Turner NC; Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom. nick.turner@icr.ac.uk.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom. |
